BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 5958698)

  • 1. Allopurinol in patients with impaired renal function.
    Levin NW; Abrahams OL
    Ann Rheum Dis; 1966 Nov; 25(6 Suppl):681-7. PubMed ID: 5958698
    [No Abstract]   [Full Text] [Related]  

  • 2. Allopurinol in treatment of patients with gout and chronic renal failure.
    Bowie EA; Simmonds HA; North JD
    N Z Med J; 1967 Sep; 66(421):606-11. PubMed ID: 5234549
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of the xanthine oxidase inhibitor, allopurinol, in the control of hyperuricaemia, gout and uric acid calculi.
    Emmerson BT
    Australas Ann Med; 1967 Aug; 16(3):205-14. PubMed ID: 6056609
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparative study of the xanthine oxidase inhibitors allopurinol and oxipurinol in man.
    Chalmers RA; Krömer H; Scott JT; Watts RW
    Clin Sci; 1968 Oct; 35(2):353-62. PubMed ID: 5721238
    [No Abstract]   [Full Text] [Related]  

  • 5. [Allopurinol in the treatment of gout and uric acid nephrolithiasis].
    Zöllner N; Schattenkirchner M
    Dtsch Med Wochenschr; 1967 Apr; 92(14):654-60. PubMed ID: 6024539
    [No Abstract]   [Full Text] [Related]  

  • 6. Allopurinol therapy of gout with renal complications.
    Sjöberg KH
    Ann Rheum Dis; 1966 Nov; 25(6 Suppl):688-90. PubMed ID: 5958699
    [No Abstract]   [Full Text] [Related]  

  • 7. Allopurinol in the prophylaxis of uric acid stones.
    de Vries A; Frank M; Liberman UA; Sperling O
    Ann Rheum Dis; 1966 Nov; 25(6 Suppl):691-3. PubMed ID: 5958700
    [No Abstract]   [Full Text] [Related]  

  • 8. Uric acid and the kidney.
    Cameron JS
    Proc R Soc Med; 1973 Sep; 66(9):900-2. PubMed ID: 4805094
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of gout with allopurinol and sulphinpyrazone in combination and with allopurinol alone.
    Kuzell WC; Seebach LM; Glover RP; Jackman AE
    Ann Rheum Dis; 1966 Nov; 25(6 Suppl):634-42. PubMed ID: 5335061
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clearance of oxypurines in normal subjects and in gout patients subjected to a purine-free diet. Effects of allopurinol].
    Porcelli B; Pizzichini M; Di Stefano A; Leoncini R; Taddeo A; Marinello E
    Boll Soc Ital Biol Sper; 1989 Nov; 65(11):1105-10. PubMed ID: 2629828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic effects of allopurinol and allo-xanthine.
    Rundles RW
    Ann Rheum Dis; 1966 Nov; 25(6 Suppl):615-20. PubMed ID: 5226510
    [No Abstract]   [Full Text] [Related]  

  • 12. A new approach to the treatment of uric acid stones with comments on xanthinuria and calculi.
    Silberman HR
    Mod Treat; 1967 May; 4(3):531-8. PubMed ID: 6045806
    [No Abstract]   [Full Text] [Related]  

  • 13. Biochemical evidence for a distinct type of primary gout.
    Sorensen LB; Benke PJ
    Nature; 1967 Mar; 213(5081):1122-3. PubMed ID: 6029792
    [No Abstract]   [Full Text] [Related]  

  • 14. [Analysis of uric acid and oxypurines in normal subjects and in gout patients].
    Porcelli B; Pizzichini M; Di Stefano A; Leoncini R; Taddeo A; Marinello E
    Boll Soc Ital Biol Sper; 1989 Dec; 65(12):1201-5. PubMed ID: 2627336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The level of oxypurines in the plasma and urine of control and gout patients. (Correlation with the level of uric acid)].
    Auscher C; Brouilhet H; Delbarre F
    Sem Hop; 1967 Apr; 43(17):1123-6. PubMed ID: 4293530
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of allopurinol on gouty and non-gouty uric acid nephropathy.
    Ogryzlo MA; Urowitz MB; Weber HM; Houpt JB
    Ann Rheum Dis; 1966 Nov; 25(6 Suppl):673-80. PubMed ID: 5958697
    [No Abstract]   [Full Text] [Related]  

  • 17. Impaired renal excretion of hypoxanthine and xanthine in primary gout.
    Puig JG; Mateos FA; Jiménez ML; Ramos T; Capitán MC; Gil AA
    Adv Exp Med Biol; 1989; 253A():269-76. PubMed ID: 2624202
    [No Abstract]   [Full Text] [Related]  

  • 18. Allopurinol in the therapy of neoplasia and blood diseases. Metabolic aspects.
    Watts RW
    Ann Rheum Dis; 1966 Nov; 25(6 Suppl):657-9. PubMed ID: 5226512
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma oxipurinol concentrations during allopurinol therapy.
    Emmerson BT; Gordon RB; Cross M; Thomson DB
    Br J Rheumatol; 1987 Dec; 26(6):445-9. PubMed ID: 3690140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allopurinol in primary gout with and after the administration of uricosuric agents.
    Kersley GD
    Ann Rheum Dis; 1966 Nov; 25(6 Suppl):643-4. PubMed ID: 5958694
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.